VistaGen Therapeutics
VTGN
VTGN
20 hedge funds and large institutions have $2.02M invested in VistaGen Therapeutics in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
61% less capital invested
Capital invested by funds: $5.23M → $2.02M (-$3.21M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$167K | |
| 2 | +$163K | |
| 3 | +$62K | |
| 4 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
+$21K |
| 5 |
CWA
Clarus Wealth Advisors
Peoria,
Arizona
|
+$14K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$926K | |
| 3 | -$154K | |
| 4 |
AWCI
Alpine Woods Capital Investors
Purchase,
New York
|
-$50K |
| 5 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$42.1K |